---
title: "ONCY.US (ONCY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ONCY.US/news.md"
symbol: "ONCY.US"
name: "ONCY.US"
parent: "https://longbridge.com/en/quote/ONCY.US.md"
datetime: "2026-05-21T02:09:18.643Z"
locales:
  - [en](https://longbridge.com/en/quote/ONCY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ONCY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ONCY.US/news.md)
---

# ONCY.US (ONCY.US) — Related News

### [Oncolytics Reports 19.5-Month Median Duration of Response in 2L KRAS-Mutant MSS mCRC](https://longbridge.com/en/news/285078415.md)
*2026-05-04T13:13:02.000Z*
> Oncolytics reported a 19.5-month median duration of response in second-line KRAS-mutant MSS metastatic colorectal cancer

### [U.S. stock night trading volatility: Oncolytics Biotech rose nearly 10% in after-hours trading, boosted by FDA key study protocol enhancing market confidence](https://longbridge.com/en/news/284467230.md)
*2026-04-29T00:36:43.000Z*
> Oncolytics Biotech rose 9.95% in after-hours trading; Compass Therapeutics had a trading volume of USD 118,000; Intellia

### [Stocks in Play: Oncolytics Biotech Inc](https://longbridge.com/en/news/284230718.md)
*2026-04-27T13:57:20.000Z*
> Oncolytics Biotech Inc announced a successful Type C meeting with the U.S. FDA regarding the pivotal clinical study desi

### [Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study | ONCY Stock News](https://longbridge.com/en/news/284212289.md)
*2026-04-27T04:10:48.000Z*
> Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study | ONCY Stock News